Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

BioDerm Announces New Partnership with CellMark Medical, a Division of CellMark AB
  • USA - English

 (PRNewsFoto/BioDerm, Inc.)

News provided by

BioDerm, Inc.

28 Jan, 2017, 03:46 IST

Share this article

Share toX

Share this article

Share toX

LARGO, Florida, Jan. 27, 2017 /PRNewswire/ -- Today BioDerm®, Inc. announced the launch of their new partnership with CellMark Medical to bring the next generation of urinary management, securement and skin protection devices into select Asian markets. BioDerm, Inc. is the manufacturer of the Men's Liberty™ and Safe n'Dry® Male Urinary Devices, the next generation hydrocolloid-based external catheters that reduce the risk of developing urinary tract infections commonly associated with indwelling catheters1 and provide a safe, skin-friendly seal for 24 hours or more.  Because of their occlusive seal and noninvasive design, they reduce the risk of catheter associated urinary tract infections, or CAUTIs, and skin macerations and injuries associated with the use of adult diapers or condom catheters when used for incontinence2.  In addition, BioDerm's CathGrip® line of medical device securement products can reduce the instances of Medical Device-Related Hospital Acquired Pressure Ulcers (HAPUs). 

"We are excited to be working with CellMark Medical to improve the quality of care that Asian patients receive in hospitals today.  We look forward to explosive growth in highly populous markets that have increasing standards of care and wealth," says BioDerm's President, Gaet Tyranski.

"CellMark Medical was formed to cost effectively bring innovative medical devices and pharmaceutical products to the world to improve quality of life.  We are pleased to partner with BioDerm to bring their unique and effective products to select Asian markets, using our proprietary trade platform, where we have an established network of distributors with broad access to end users," says CellMark Medical's President, Niclas Mottus Olsson.

Headquartered in Largo, Florida, BioDerm is one of the nation's leading manufacturers of proprietary hydrocolloid products for urinary management, securement, infection control and skin protection. The company challenges accepted inferior standards of care by creating products that reduce infection rates, reduce pressure injuries, add comfort and reliability, and vastly improve quality of life. Our products are sold world-wide and our brands include Men's Liberty™, Safe n'Dry®, CathGrip®, BioPlus+™ and FreeDerm™.  You can find more info here: http://www.bioderminc.com 

Headquartered in Gothenburg, Sweden, CellMark Medical leverages an expert global trading infrastructure, with a network across 120 markets, to simplify the exporting process and minimize associated risks, allowing MedTech manufacturers transparent control of their international sales operations.  CellMark Medical sources qualified, trusted and well-established distribution partners in chosen markets.  CellMark offers producers and end-users all manner of sales and marketing services, timely, accurate market information, risk management, order tracking, invoicing and trade documentation, all of which contribute to world-class medical device supply chain service operations.  CellMark Medical manages marketing literature and packaging design, development and implementation in local markets.  CellMark Medical coordinates the regulatory approval process in the local market, ensuring the necessary documents are comprehensively vetted and delivered to the correct authorities in a timely manner, leveraging an in-depth network of experts to quickly overcome any local obstacles.  CellMark provides Trademark registration services and applies for and holds product registrations locally, on behalf of the product owner.  The licenses can be transferred back at any time to ensure the manufacturer has full control of the future of their business.  More information can be found here: http://www.cellmark.com/divisions-business-units/medical/   

1 May/June2016;43(3):301-307. Published by Lippincott Williams & Wilkins
External Collection Devices as an Alternative to the Indwelling Urinary Catheter
Evidence-Based Review and Expert Clinical Panel Deliberations
Mikel Gray, Claudia Skinner, Wendy Kaler

2 http://www.hospimedica.com/critical-care/articles/294748243/male-urinary-device-addresses-patient-management-challenges.html

Contact: Wendy LaTorre
BioDerm, Inc.
12320 73rd Ct. N, Largo, FL 33773 USA
+1(727)800-1976
[email protected]

Logo - http://mma.prnewswire.com/media/462295/BioDerm_Logo.jpg  

Related Links

http://www.bioderm-inc.com

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.